Sign in
R&D
Clinical
Commercial
Brand & Marketing
Technology
Insights
Podcast
Awards
LSV Top Industry Leaders Award 2025 Nominations
LSV Rising Stars Award 2025 Winner List
More
Manufacturing
Regulatory
Editorial
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
LifeNews
Life Science
Fashion Trends and Culture
R&D
Research & Development
Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028
August 31, 2025
Research & Development
Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs
July 30, 2025
Research & Development
$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases
July 11, 2025
Research & Development
Scientists Identify New Target to Prevent Cancer from Spreading to Bones
May 22, 2025
Clinical
Clinical
Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD
October 22, 2025
Clinical
Tvardi Therapeutics Reports Phase 2 Failure for IPF Drug Candidate TTI-101
October 17, 2025
Clinical
Moderna Reveals Promising Melanoma Data Behind Decision to Proceed With Cancer Candidate
October 15, 2025
Clinical
Amgen reports Vesalius-CV topline showing Repatha reduces MACE in primary-prevention patients
October 3, 2025
Commercial
All
Brand & Marketing
Commercial
Johnson & Johnson to Spin Off Orthopedics Business as DePuy Synthes in 18 to 24 Months
October 17, 2025
Commercial
AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases
October 15, 2025
Commercial
Novo Pens $5.2B Deal to Acquire Akero, Entering Liver Disease Space
October 15, 2025
Technology
Technology
Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI
July 7, 2025
Technology
J&J MedTech presents the first Ottava surgical robot clinical cases
April 17, 2025
Commercial
Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
October 23, 2024
Technology
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
September 26, 2024
Insights
Insights
Reg impact assessment next in GenAI’s sights, experts claim
June 26, 2025
Insights
The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption
December 1, 2024
Insights
Improving life science R&D outcomes with AI
November 8, 2024
Insights
The medical device sector’s surging regulatory burden: how are suppliers coping?
October 12, 2024
Podcast
Awards
LSV Top Industry Leaders Award 2025 Nominations
LSV Rising Stars Award 2025 Winner List
More
Manufacturing
Regulatory
Editorial
type here...
Search
Facebook
Linkedin
Twitter
Latest news
Clinical
October 22, 2025
Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD
Key Takeaways: Alector is discontinuing the development of latozinemab for frontotemporal dementia (FTD) after it failed to meet its...
Regulatory
October 22, 2025
FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s oral semaglutide therapy Rybelsus to lower the risk...
Regulatory
October 21, 2025
FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis
FDA Approves New Treatment for Lupus Nephritis Roche has received U.S. Food and Drug Administration (FDA) approval for its medicine...
Manufacturing
October 21, 2025
Merck expands once more as part of a planned $70 billion US investment
Merck's New Virginia Plant Merck has launched a new $3 billion plant on its large manufacturing campus in Elkton, Virginia....
Clinical
October 17, 2025
Tvardi Therapeutics Reports Phase 2 Failure for IPF Drug Candidate TTI-101
Phase 2 Trial Fails to Meet Objectives Drug development efforts...
Regulatory
October 17, 2025
BioCryst Pens $700M Deal to Acquire Astria, Strengthening Rare Disease Focus
Major Acquisition in Rare Disease Space BioCryst Pharmaceuticals, which has...
Regulatory
October 17, 2025
Kailera Therapeutics Secures $600 Million Series B to Advance Global Obesity Drug Program
Kailera Therapeutics Secures Major Funding Kailera Therapeutics has raised $600 million in a Series B financing to support the advancement...
Commercial
October 17, 2025
Johnson & Johnson to Spin Off Orthopedics Business as DePuy Synthes in 18 to 24 Months
A New Chapter for J&J's Orthopedics Division Johnson & Johnson (J&J) has announced plans to separate its orthopedics division into...
Manufacturing
October 15, 2025
LTS Lohmann Acquires Renaissance Lakewood to Expand U.S. CDMO Capabilities
German pharmaceutical technology company LTS Lohmann is expanding its operations in the United States through the acquisition of Renaissance...
Regulatory
October 15, 2025
Regeneron Reports New Data on Gene Therapy for Hearing Loss, Advances CHORD Trial Toward FDA Submission
DB-OTO Gene Therapy Shows Promise in Restoring Hearing Regeneron Pharmaceuticals...
Clinical
October 15, 2025
Moderna Reveals Promising Melanoma Data Behind Decision to Proceed With Cancer Candidate
Promising Early Results Moderna has released early clinical data that...
Commercial
October 15, 2025
AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases
A Landmark Partnership in Gene Therapy AviadoBio has obtained an exclusive option for a gene therapy targeting rare eye diseases...
Commercial
October 15, 2025
Novo Pens $5.2B Deal to Acquire Akero, Entering Liver Disease Space
The Agreement Novo Nordisk has agreed to acquire Akero Therapeutics in a deal valued at $5.2 billion, marking another major...
Regulatory
October 13, 2025
FDA Approves Regeneron’s Libtayo for High-Risk Skin Cancer as Adjuvant Therapy
New Hope for High-Risk Skin Cancer Patients The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals’ Libtayo (cemiplimab)...
Regulatory
FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients
The U.S. Food and Drug Administration (FDA) has approved...
Editotial Team
-
Commercial
Johnson & Johnson to Spin Off Orthopedics Business as DePuy Synthes in 18 to 24 Months
A New Chapter for J&J's Orthopedics Division Johnson & Johnson...
Editotial Team
-
Commercial
Philips and Masimo Extend Partnership for Patient Monitoring Technologies
Strategic Renewal Philips and Masimo have renewed their multi-year strategic...
Commercial
AstraZeneca Acquires Amolyt Pharma, Expanding into Rare Endocrinology
AstraZeneca has made a strategic move into the realm...
Popular
Most popular life news you must read today
View all articles
Insights
Parkinson’s, autism spectrum disorder, and the gut-brain axis: A role for psychobiotics in ameliorating neurological symptoms from the gut
June 2, 2022
Insights
A Patient Centric Approach to Clinical Research is Key for Product Development
February 22, 2023
Clinical
Vertex Presses Pause on CF Study, Reports Major Write-Down
May 9, 2025
Commercial
Johnson & Johnson to Spin Off Orthopedics Business as DePuy Synthes in 18 to 24 Months
Editotial Team
-
October 17, 2025
AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases
Editotial Team
-
October 15, 2025
Novo Pens $5.2B Deal to Acquire Akero, Entering Liver Disease Space
Editotial Team
-
October 15, 2025
Evommune Seeks IPO to Advance Work on Immune Drug
Editotial Team
-
October 13, 2025
Bristol Myers Squibb to Acquire Orbital Therapeutics in $1.5 Billion Deal to Expand In Vivo Cell Therapy Portfolio
Editotial Team
-
October 13, 2025
AstraZeneca Joins Hands With Algen in $555M Immunology Targets Deal
Editotial Team
-
October 9, 2025
Information Technology
Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI
Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team
-
July 7, 2025
J&J MedTech presents the first Ottava surgical robot clinical cases
Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team
-
April 17, 2025
Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances
Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team
-
October 23, 2024
PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm
Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team
-
September 26, 2024
Regulatory
Regulatory
FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients
The U.S. Food and Drug Administration (FDA) has approved...
Editotial Team
-
Regulatory
FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients
The U.S. Food and Drug Administration (FDA) has approved...
Regulatory
FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis
FDA Approves New Treatment for Lupus Nephritis Roche has received...
Manufacturing
Merck expands once more as part of a planned $70 billion US investment
Merck's New Virginia Plant Merck has launched a new $3...
Regulatory
FDA Gives Green Light to Glaukos’ Eye Disorder Therapy
Understanding Keratoconus The FDA has approved Glaukos’ corneal treatment, Epioxa,...
Research & Development
Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028
August 31, 2025
Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs
July 30, 2025
$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases
July 11, 2025
Scientists Identify New Target to Prevent Cancer from Spreading to Bones
May 22, 2025
Market Access
Merck expands once more as part of a planned $70 billion US investment
October 21, 2025
LTS Lohmann Acquires Renaissance Lakewood to Expand U.S. CDMO Capabilities
October 15, 2025
Aerska Launches with $21 Million to Develop RNAi Medicines for Neurological Diseases
October 8, 2025
With a $70 million expansion in Massachusetts, AbbVie plans the next phase of its US investment adventure
October 8, 2025
Manufacturing
August 18, 2025
Generation Bio Lays Off 90% of Workforce Amid Funding Challenges for Autoimmune Drug Delivery Technology
Massachusetts-based biotech company Generation Bio has announced a massive...
Manufacturing
August 17, 2025
Philips to Invest Over $150 Million in Expanding U.S. Manufacturing and R&D
Philips has announced it will invest more than $150...
Manufacturing & Regulatory
POPULAR
Find Your Perfect Music Festival
Clinical
Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD
Key Takeaways: Alector is discontinuing the development of latozinemab...
Editotial Team
-
Manufacturing
LTS Lohmann Acquires Renaissance Lakewood to Expand U.S. CDMO Capabilities
German pharmaceutical technology company LTS Lohmann is expanding its...
Editotial Team
-
Regulatory
FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis
FDA Approves New Treatment for Lupus Nephritis Roche has received...
Editotial Team
-